Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Recipharm Stockholm AB
AB
In liquidation
Org 5566668249
Stockholm
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2004
0 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Recipharm Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JA
Jan Anders Fredrik Lovén
Liquidator
Liquidator
2025
LA
Lars Anders Larsson
Liquidator
Liquidator
2025
Former (3)
EG
Erik Gunnar Hagman
Chief Executive Officer
Chief Executive Officer
2020 – 2020
TB
Thomas Bengt Eldered
External Signatory
External Signatory
2020 – 2021
JE
Josefine Emma Elvira Vestlund
Authorized Recipient of Service
Authorized Recipient of Service
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (16)
JT
Jan Totte Dahlin
Board of Directors
2025 – 2025
LJ
Lars Jörgen Rahm
Board of Directors
2024 – 2024
SC
Susanne Canohn
Deputy Board Member
2020 – 2021
JM
Johanna Mirjam Kvist
Board of Directors
2020 – 2024
KM
Karl Martin Lejontand
Deputy Board Member
2020 – 2022
NA
Nese Akay Kemahli
Chairman
2022 – 2022
GJ
Gregor Johann Kawaletz
Deputy Board Member
2022 – 2025
RE
Rut Eva Maria Ekedahl
Board of Directors
2020 – 2021
OB
Ozrenka Brezar
Deputy Board Member
2020 – 2021
KE
Kent Eric Roland Berg
Board of Directors
2020 – 2021
VS
Valur Sveinbjörnsson
Board of Directors
2024 – 2025
EK
Elmedina Kusmic
Board of Directors
2020 – 2021
BE
Bo Erik Gösta Haeffler
Chairman
2020 – 2021
DS
Daniela Sylvia Beate Dr. Roxin
Board of Directors
2022 – 2022
OA
Oskar Andreas Lundström
Deputy Board Member
2025 – 2025
TH
Thord Herman Emil Hargestam
Deputy Board Member
2025 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Recipharm AB
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Recipharm Stockholm AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network